Logo do repositório
 

International recommendations for training future toxicologic pathologists participating in regulatory-type, nonclinical toxicity studies

dc.contributor.authorBolon, Brad
dc.contributor.authorBarale-Thomas, Erio
dc.contributor.authorBradley, Alys
dc.contributor.authorEttlin, Robert A.
dc.contributor.authorFranchi, Carla Adriene da Silva [UNESP]
dc.contributor.authorGeorge, Catherine
dc.contributor.authorGiusti, Anna Maria
dc.contributor.authorHall, Robert
dc.contributor.authorJacobsen, Matthew
dc.contributor.authorKonishi, Yoichi
dc.contributor.authorLedieu, David
dc.contributor.authorMorton, Daniel
dc.contributor.authorPark, Jae-Hak
dc.contributor.authorScudamore, Cheryl L.
dc.contributor.authorTsuda, Hiroyuki
dc.contributor.authorVijayasarathi, S. K.
dc.contributor.authorWijnands, Marcel V. W.
dc.contributor.institutionGEMpath Inc
dc.contributor.institutionCharles River Labs
dc.contributor.institutionEttlin Consulting Ltd
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionIpsen
dc.contributor.institutionAccelera
dc.contributor.institutionCovance Labs
dc.contributor.institutionAstraZeneca
dc.contributor.institutionNovartis Pharma AG
dc.contributor.institutionPfizer
dc.contributor.institutionSeoul Natl Univ
dc.contributor.institutionUniv London Royal Vet Coll
dc.contributor.institutionNagoya City Univ
dc.contributor.institutionAdvinus Therapeut Pvt Ltd
dc.contributor.institutionMerck Sharp & Dohme Ltd
dc.contributor.institutionJohnson & Johnson PRD
dc.date.accessioned2014-05-20T15:30:33Z
dc.date.available2014-05-20T15:30:33Z
dc.date.issued2011-01-01
dc.description.abstractThe International Federation of Societies of Toxicologic Pathologists (IFSTP) proposes a common global framework for training future toxicologic pathologists who will support regulatory-type - nonclinical toxicology studies. Trainees optimally should undertake a scientific curriculum of at least 5 years at an accredited institution leading to a clinical degree (veterinary medicine or medicine). Trainees should then obtain 4 or more years of intensive pathology practice during a residency and/or on-the-job "apprenticeship," at least 2 years of which must be focused on regulatory-type toxicologic pathology topics. Possession of a recognized pathology qualification (i.e., certification) is highly recommended. A nonclinical pathway (e.g., a graduate degree in medical biology or pathology) may be possible if medically trained pathologists are scarce, but this option is not optimal. Regular, lifelong continuing education (peer review of nonclinical studies, professional meetings, reading, short courses) will be necessary to maintain and enhance one's understanding of current toxicologic pathology knowledge, skills, and tools. This framework should provide a rigorous yet flexible way to reliably train future toxicologic pathologists to generate, interpret, integrate, and communicate data in regulatory-type, nonclinical toxicology studies. (C) 2010 Reprinted by Permission of SAGE Publications Inc. Published by Elsevier GmbH. All rights reserved.en
dc.description.affiliationGEMpath Inc, Longmont, CO USA
dc.description.affiliationCharles River Labs, Edinburgh, Midlothian, Scotland
dc.description.affiliationEttlin Consulting Ltd, Muenchenstein, Switzerland
dc.description.affiliationUniv Estadual Paulista, UNESP, Paulista, Brazil
dc.description.affiliationIpsen, Les Ulis, France
dc.description.affiliationAccelera, Nerviano, Italy
dc.description.affiliationCovance Labs, Madison, WI USA
dc.description.affiliationAstraZeneca, Macclesfield, Cheshire, England
dc.description.affiliationNovartis Pharma AG, Basel, Switzerland
dc.description.affiliationPfizer, Groton, CT USA
dc.description.affiliationSeoul Natl Univ, Seoul, South Korea
dc.description.affiliationUniv London Royal Vet Coll, Hatfield, Herts, England
dc.description.affiliationNagoya City Univ, Grad Sch Med Sci, Nagoya, Aichi, Japan
dc.description.affiliationAdvinus Therapeut Pvt Ltd, Bangalore, Karnataka, India
dc.description.affiliationMerck Sharp & Dohme Ltd, Oss, Netherlands
dc.description.affiliationJohnson & Johnson PRD, Beerse, Belgium
dc.description.affiliationUnespUniv Estadual Paulista, UNESP, Paulista, Brazil
dc.format.extent187-195
dc.identifierhttp://dx.doi.org/10.1016/j.etp.2010.07.006
dc.identifier.citationExperimental and Toxicologic Pathology. Jena: Elsevier Gmbh, Urban & Fischer Verlag, v. 63, n. 1-2, p. 187-195, 2011.
dc.identifier.doi10.1016/j.etp.2010.07.006
dc.identifier.issn0940-2993
dc.identifier.urihttp://hdl.handle.net/11449/39901
dc.identifier.wosWOS:000286779300027
dc.language.isoeng
dc.publisherElsevier Gmbh, Urban & Fischer Verlag
dc.relation.ispartofExperimental and Toxicologic Pathology
dc.relation.ispartofjcr2.023
dc.relation.ispartofsjr0,551
dc.rights.accessRightsAcesso restrito
dc.sourceWeb of Science
dc.subjectToxicologic pathologistsen
dc.subjectEducationen
dc.subjectTrainingen
dc.subjectExperienceen
dc.subjectRegistrationen
dc.subjectAccreditationen
dc.subjectRecognitionen
dc.titleInternational recommendations for training future toxicologic pathologists participating in regulatory-type, nonclinical toxicity studiesen
dc.typeArtigo
dcterms.licensehttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
dcterms.rightsHolderElsevier Gmbh, Urban & Fischer Verlag
dspace.entity.typePublication
unesp.author.lattes9163387140787963[5]
unesp.author.orcid0000-0002-2830-2540[5]
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Medicina, Botucatupt
unesp.departmentPatologia - FMBpt

Arquivos

Licença do pacote

Agora exibindo 1 - 2 de 2
Carregando...
Imagem de Miniatura
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição:
Carregando...
Imagem de Miniatura
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição: